tebentafusp-tebn 100 MCG in 0.5 ML Injection

RxCUI: 2590748
RxNorm name: tebentafusp-tebn 100 MCG in 0.5 ML Injection
Display name: tebentafusp-tebn 100 MCG in 0.5 ML Injection
Full name: tebentafusp-tebn 100 MCG in 0.5 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761228	Kimmtrak	tebentafusp-tebn	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KIMMTRAK	TEBENTAFUSP	Immunocore Commercial LLC	24a49f57-d2fc-4ffe-9eb1-fe0460c6b067	2025-05-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2590748

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
24a49f57-d2fc-4ffe-9eb1-fe0460c6b067	tebentafusp-tebn 100 MCG in 0.5 ML Injection	PSN	8	These highlights do not include all the information needed to use KIMMTRAK ® safely and effectively. See full prescribing information for KIMMTRAK ® . KIMMTRAK ® (tebentafusp-tebn) injection, for intravenous use Initial U.S. Approval: 2022	20250506
24a49f57-d2fc-4ffe-9eb1-fe0460c6b067	0.5 ML tebentafusp-tebn 0.2 MG/ML Injection	SCD	8	These highlights do not include all the information needed to use KIMMTRAK ® safely and effectively. See full prescribing information for KIMMTRAK ® . KIMMTRAK ® (tebentafusp-tebn) injection, for intravenous use Initial U.S. Approval: 2022	20250506
24a49f57-d2fc-4ffe-9eb1-fe0460c6b067	tebentafusp-tebn 100 MCG per 0.5 ML Injection	SY	8	These highlights do not include all the information needed to use KIMMTRAK ® safely and effectively. See full prescribing information for KIMMTRAK ® . KIMMTRAK ® (tebentafusp-tebn) injection, for intravenous use Initial U.S. Approval: 2022	20250506